3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
5
Cyclophosphamide
5
Nivolumab
4
Psychiatric Rehabilitation
3
Paclitaxel
3
Flow Cytometry
3
Filgrastim
3
valspodar
2
sargramostim
2
fludarabine
2
epacadostat
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Surveys and Questionnaires
2
Microarray Analysis
2
Methylprednisolone
2
Melphalan
2
Interleukin-2
2
Immunologic Techniques
2
Early Intervention, Educational
2
Dexamethasone
2
Dasatinib
2
Carboplatin
2
Biopsy
2
Azacitidine
2
Analgesia
2
Amifostine
2
Alemtuzumab
2
vocimagene amiretrorepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Referral and Consultation
×
Gynecologic
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts